FDA regulators put their highest-risk label on Merit Medical’s recall of kits containing 1% Lidocaine HCl injections manufactured by Hospira. FDA officials put their highest-risk Class I label on a recall of certain Merit Medical Systems (NSDQ:MMSI) procedural trays and kits over concerns about 1% Lidocaine HCl injections manufactured by Hospira (NYSE:HSP). he injections were recalled after 1 confirmed customer report of red and black particulate in the container, according to the FDA memo.
Help employers find you! Check out all the jobs and post your resume.
